ArticleOncoTargets and therapy2016

Structure-activity relationships study of mTOR kinase inhibition using QSAR and structure-based drug design approaches.

Wiame Lakhlili et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.